Correlation Between INPOST SA and BioNTech
Specify exactly 2 symbols:
By analyzing existing cross correlation between INPOST SA EO and BioNTech SE, you can compare the effects of market volatilities on INPOST SA and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INPOST SA with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of INPOST SA and BioNTech.
Diversification Opportunities for INPOST SA and BioNTech
Very weak diversification
The 3 months correlation between INPOST and BioNTech is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding INPOST SA EO and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and INPOST SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INPOST SA EO are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of INPOST SA i.e., INPOST SA and BioNTech go up and down completely randomly.
Pair Corralation between INPOST SA and BioNTech
Assuming the 90 days horizon INPOST SA EO is expected to generate 0.96 times more return on investment than BioNTech. However, INPOST SA EO is 1.04 times less risky than BioNTech. It trades about -0.12 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.15 per unit of risk. If you would invest 1,645 in INPOST SA EO on December 24, 2024 and sell it today you would lose (253.00) from holding INPOST SA EO or give up 15.38% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
INPOST SA EO vs. BioNTech SE
Performance |
Timeline |
INPOST SA EO |
BioNTech SE |
INPOST SA and BioNTech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with INPOST SA and BioNTech
The main advantage of trading using opposite INPOST SA and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INPOST SA position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.INPOST SA vs. AIR PRODCHEMICALS | INPOST SA vs. Japan Post Insurance | INPOST SA vs. Soken Chemical Engineering | INPOST SA vs. TIANDE CHEMICAL |
BioNTech vs. Yunnan Water Investment | BioNTech vs. STORE ELECTRONIC | BioNTech vs. Nanjing Panda Electronics | BioNTech vs. ELECTRONIC ARTS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |